Hematology/Oncology

Top Story

Early tumor shrinkage associated with OS benefit from cabozantinib in advanced kidney cancer

February 18, 2019
In the Journals Plus

'Timing really matters' in link between DDT exposure, breast cancer risk

February 18, 2019
Women exposed to the insecticide p,p’-DDT appeared at increased risk for breast cancer through age 54 years, according to results of a prospective study published…
Feature

Stanford’s WellMD Center blazes a trail to promote joy in medicine, combat burnout

February 18, 2019
Physician burnout has become a topic of interest in the medical community in recent years, with the level of urgency increasing on what seems like a weekly basis. In a…
Meeting News

Malignant pheochromocytomas harbor a variety of genomic alterations

February 17, 2019
SAN FRANCISCO — Malignant pheochromocytomas appeared to feature a variety of genomic alterations, some of which, including RET, NF1 and FGFR1, may be potential…
Meeting News

Immunotherapy 'tidal wave' demands interdisciplinary approach

February 16, 2019
SCOTTSDALE, Ariz. — In the face of the “tidal wave of cancer immunotherapy,” collaboration across disciplines is required to manage immune-related…
More Headlines »
CME ABIM MOC

Ace the Case: A 72-Year-Old Man With Fatigue, Weight Loss, and Lymphocytosis

There is no commercial support for this activity.

This educational activity will review the diagnosis and management of a 72-year-old man with complaints of increasing…
More »
Video
Meeting News

VIDEO: Ibrutinib yields superior PFS vs. standard care in chronic lymphocytic leukemia

December 13, 2018
More »
Resource Centers
ASH Annual Meeting and Exposition

ASH Annual Meeting and Exposition

CME CNE CPE

Advances in the Management of Toxicities Associated with Stem Cell Transplant

This activity is supported by an educational grant from Cumberland Pharmaceuticals.

Therapeutic options for the treatment of multiple myeloma continue to evolve. Currently, high-dose melphalan followed…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next